Global X Video Games & Esports ETF

27.01

-0.1300-0.48%

Post-market: 27.020.0100+0.04%16:15 EST

Volume:8.22K

Turnover:221.93K

Market Cap:85.89M

PE:-0.04

High:27.18

Open:26.82

Low:26.82

Close:27.14

52wk High:34.68

52wk Low:22.80

Shares:3.18M

Float Shares:3.18M

Volume Ratio:0.51

T/O Rate:0.26%

Dividend:0.48

Dividend Rate:1.79%

EPS(TTM):-662.1600

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Press Release: SurgePays Revenue for the Third Quarter 2025 Increases 292% Year-Over-Year and 62% Sequentially

Dow Jones

·

Nov 12, 2025

Aardvark Therapeutics Announces FDA Alignment on Protocol Amendment Expanding Phase 3 HERO Trial Population for Prader-Willi Syndrome

GlobeNewswire

·

Oct 08, 2025

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/HERO/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"HERO","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"HERO\",,,,,undefined,":{"symbol":"HERO","market":"US","secType":"STK","nameCN":"Global X Video Games & Esports ETF","latestPrice":27.01,"timestamp":1771966800000,"preClose":27.14,"halted":0,"volume":8217,"hourTrading":{"tag":"盘后","latestPrice":27.02,"preClose":27.01,"latestTime":"16:15 EST","volume":28,"amount":755.7101160000001,"timestamp":1771967705903,"change":0.01,"changeRate":0.00037,"amplitude":0.00037},"delay":0,"changeRate":-0.00478997789240969,"floatShares":3180000,"shares":3180000,"eps":-662.16,"marketStatus":"Post-Mkt","change":-0.13,"latestTime":"02-24 18:38:51 EST","open":26.82,"high":27.18,"low":26.82,"amount":221926.8179,"amplitude":0.013265,"askPrice":29.52,"askSize":100,"bidPrice":26.75,"bidSize":4,"shortable":3,"etf":1,"ttmEps":-662.16,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1771981200000},"marketStatusCode":4,"adr":0,"listingDate":1572494400000,"exchange":"NASDAQ","adjPreClose":27.14,"sharesOutstanding":3180000,"nav":27.19,"aum":86468977.03,"dividendRate":0.017882,"bidAskSpread":0,"preHourTrading":{"tag":"盘前","latestPrice":27.05,"preClose":27.14,"latestTime":"09:11 EST","volume":2,"amount":54.1,"timestamp":1771942276858,"change":-0.09,"changeRate":-0.003316,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":27.02,"preClose":27.01,"latestTime":"16:15 EST","volume":28,"amount":755.7101160000001,"timestamp":1771967705903,"change":0.01,"changeRate":0.00037,"amplitude":0.00037},"volumeRatio":0.513255,"impliedVol":0.0539,"impliedVolPercentile":0.239},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"HERO\",,,,,undefined,":{"symbol":"HERO","floatShares":3180000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.513255,"shares":3180000,"dividePrice":0.483,"high":27.18,"amplitude":0.013265,"preClose":27.14,"low":26.82,"week52Low":22.8,"pbRate":"--","week52High":34.68,"institutionHeld":0.5073,"latestPrice":27.01,"committee":-0.923077,"eps":-662.16,"divideRate":0.017882,"volume":8217,"delay":0,"ttmEps":-662.16,"open":26.82,"prevYearClose":29.7565,"prevWeekClose":27.29,"prevMonthClose":29.54,"prevQuarterClose":29.7565,"fiveDayClose":27.23,"twentyDayClose":30.92,"sixtyDayClose":31.06},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/HERO\",params:#limit:5,,,undefined,":[{"date":"2025-12-30","symbol":"HERO","amount":0.332932,"announcedDate":"2025-12-29","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-30","defaultRemindTime":1767105000000,"name":"Global X Video Games & Esports ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-01-07","payableDate":"2025-12-30","currency":"USD","dateTimestamp":1767070800000,"payDate":"2026-01-07"},{"date":"2025-06-27","symbol":"HERO","amount":0.14964,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-27","defaultRemindTime":1751031000000,"name":"Global X Video Games & Esports ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-07-07","payableDate":"2025-06-27","currency":"USD","dateTimestamp":1750996800000,"payDate":"2025-07-07"},{"date":"2024-12-30","symbol":"HERO","amount":0.20754,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-30","defaultRemindTime":1735569000000,"name":"Global X Video Games & Esports ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-01-07","payableDate":"2024-12-30","currency":"USD","dateTimestamp":1735534800000,"payDate":"2025-01-07"},{"date":"2024-06-27","symbol":"HERO","amount":0.04107,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-06-27","defaultRemindTime":1719495000000,"name":"Global X Video Games & Esports ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-07-05","payableDate":"2024-06-27","currency":"USD","dateTimestamp":1719460800000,"payDate":"2024-07-05"},{"date":"2023-12-28","symbol":"HERO","amount":0.120779,"announcedDate":"2023-12-27","type":"dividend","market":"US","newRecordDate":"2023-12-29","defaultRemindTime":1703773800000,"name":"Global X Video Games & Esports ETF","recordDate":"2024-01-08","payableDate":"2023-12-29","currency":"USD","dateTimestamp":1703739600000,"payDate":"2024-01-08"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"HERO\",market:\"US\",,,undefined,":[{"executeDate":"2019-12-30","recordDate":"2019-12-31","paymentDate":"2020-01-08","value":0.027784,"currency":"USD"},{"executeDate":"2020-06-29","recordDate":"2020-06-30","paymentDate":"2020-07-08","value":0.012223,"currency":"USD"},{"executeDate":"2020-12-30","recordDate":"2020-12-31","paymentDate":"2021-01-08","value":0.003605,"currency":"USD"},{"executeDate":"2021-06-29","recordDate":"2021-06-30","paymentDate":"2021-07-08","value":0.025409,"currency":"USD"},{"executeDate":"2021-12-30","recordDate":"2021-12-31","paymentDate":"2022-01-07","value":0.06645,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"HERO\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"HERO\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2582775753","title":"Press Release: SurgePays Revenue for the Third Quarter 2025 Increases 292% Year-Over-Year and 62% Sequentially","url":"https://stock-news.laohu8.com/highlight/detail?id=2582775753","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582775753?lang=en_us&edition=fundamental","pubTime":"2025-11-12 22:20","pubTimestamp":1762957200,"startTime":"0","endTime":"0","summary":"Third quarter 2025 revenue totaled approximately $18.7 million, an increase of 292% year-over-year and 62% sequentially. Company is reiterating revenue guidance for 2026 of $225 million. BARTLETT, Tenn., Nov. 12, 2025  -- SurgePays, Inc.  , a wireless and fintech technology company connecting subprime and underserved consumers to essential mobile and financial services, today announced revenue growth of 292% year-over-year and 62% sequentially to $18.7 million for the third quarter ended September 30, 2025. The Company is reiterating revenue guidance of $225 million for 2026.Mr. Cox concluded, \"As we continue to scale our platform and expand our leadership across the subprime and underserved markets, we are confident in our ability to deliver strong growth and achieve our 2026 revenue guidance of $225 million.\". -- Torch Wireless, SurgePays' Lifeline-subsidized brand, continued to be a. SurgePays' ability to capture market share in the prepaid wireless. partners, including HT Hackney, ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HERO","BK4132","SURG"],"gpt_icon":0},{"id":"2573928291","title":"Aardvark Therapeutics Announces FDA Alignment on Protocol Amendment Expanding Phase 3 HERO Trial Population for Prader-Willi Syndrome","url":"https://stock-news.laohu8.com/highlight/detail?id=2573928291","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2573928291?lang=en_us&edition=fundamental","pubTime":"2025-10-08 20:00","pubTimestamp":1759924800,"startTime":"0","endTime":"0","summary":"Protocol Expansion to Ages 10+ Aligned with FDA Guidance, Broadening Patient PopulationSAN DIEGO, Oct.  08, 2025  (GLOBE NEWSWIRE) -- Aardvark Therapeutics, Inc. (Aardvark) (Nasdaq: AARD), a clinical-","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/10/08/3163296/0/en/Aardvark-Therapeutics-Announces-FDA-Alignment-on-Protocol-Amendment-Expanding-Phase-3-HERO-Trial-Population-for-Prader-Willi-Syndrome.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PWS","CCK","LU1267930490.SGD","LU0211328371.USD","LU0029864427.USD","BK4126","LU0029874061.USD","LU0128526141.USD","LU0310800379.SGD","LU0708994859.HKD","LU1803068623.USD","LU1892829315.USD","LU0310799852.SGD","LU0128525929.USD","LU0211327993.USD","HERO","LU1267930573.SGD","AARD"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":2,"code":"91000000","status":"200"}]}}